Wolfgang Miesbach: Exceptional Presentation on the Role of vWF in Angiogenesis and Gut Angiodysplasia in VWD
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Outstanding science at EAHAD 2026 in Dublin!
One of the highlights of this year’s congress was the exceptional presentation by Anna Randi on the fascinating — and still underappreciated — role of Von Willebrand Factor in angiogenesis and gut angiodysplasia in VWD, why VWF replacement therapy fails in GI bleeding — and what we can do about it.
The clinical problem: 5–20% of VWD patients suffer recurrent, intractable GI bleeding from angiodysplasia — dilated, fragile mucosal vessels prone to rupture.
VWF/FVIII concentrates reduce joint bleeds effectively, but annualised GI bleed rates remain stubbornly high (median 6 episodes/year even on prophylaxis, VWD-PN data).
Beyond the gut: Vascular abnormalities in VWD are not restricted to the GI tract. A scoping review of 61 studies and 146 patients confirmed malformations also in the mouth and face, skin, spleen, brain (AVMs), and genitourinary tract — with 15 patients documented as having HHT. All subtypes are affected, most frequently type 2A, 2B, and type 3.
The mechanism: VWF is not just a haemostatic protein — it is essential for forming Weibel-Palade Bodies (WPB) in endothelial cells. WPBs store Angiopoietin-2 (Angpt-2); without VWF, Angpt-2 leaks out continuously, disrupting the Angpt-1/Angpt-2 balance at the TIE2 receptor, driving pathological sprouting angiogenesis, vascular permeability, and inflammation.
The evidence: VWF-deficient ECs show increased tube formation, increased migration (reversed by VEGFR-2 inhibitor SU4312), and increased Angpt-2 secretion — confirmed in Matrigel, zebrafish models, and human colon tissue.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Apr 7, 2026, 17:30Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
-
Apr 7, 2026, 17:28Amanda Johnson: The Stretch of Science in the History of EDS
-
Apr 7, 2026, 17:21Seema Dawood: What is Polycythemia Vera?
-
Apr 7, 2026, 16:57Sheila Cristina Ouriques Martins: Digital Solutions Can Be Embedded into Health Systems to Transform Stroke Care
-
Apr 7, 2026, 16:49Mavis Agnes Kisakye: Strengthening Healthcare Access for Bleeding Disorders in Uganda
-
Apr 7, 2026, 16:44A Call to Get the Biotech Act Right for The Millions Living with Bleeding Disorders – EHC
-
Apr 7, 2026, 16:40Pooja Choradia: Understanding Consumption Coagulopathy in Acute Pulmonary Embolism
-
Apr 7, 2026, 16:06Mohamed Elsafy։ Rethinking Hemostatic Management in Glanzmann Thrombasthenia with Sutacimig
-
Apr 7, 2026, 16:03Frits Rosendaal Is The 2026 Recipient of the ISTH Robert P. Grant Medal